Aripiprazole Tablet
Product Images NDC 76282-046

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 76282-046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aripiprazole10mg30's (Aripiprazole10mg30s)

Label for Aripiprazole Tablets 10 mg from Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-046-30 and instructions for pharmacists to dispense the Medication Guide separately. It states each tablet contains 10 mg of aripiprazole USP. The label notes storage instructions and manufacturing details, including Exelan Pharmaceuticals in Lawrenceville, GA, and Ascent Pharmaceuticals in Central Islip, NY. The package size is 30 tablets.*

FDA Label Image

Aripiprazole15mg30's (Aripiprazole15mg30s)

Aripiprazole Tablets 15 mg oral dosage form packaging label by Exelan Pharmaceuticals, Inc. Contains 30 tablets per bottle. The label includes a barcode, NDC number 76282-047-30, and instructions for pharmacist dispensing of a medication guide. Storage instructions and manufacturer details for Exelan Pharmaceuticals, Inc. and Ascent Pharmaceuticals, Inc. are noted.*

FDA Label Image

Aripiprazole20mg30's (Aripiprazole20mg30s)

Aripiprazole Tablets 20 mg label from Exelan Pharmaceuticals, Inc. The label shows the proprietary name, dosage strength, and form. It includes the NDC number 76282-048-30, dispensing instructions for pharmacists, storage directions, and manufacturer details. The package contains 30 tablets.*

FDA Label Image

Aripiprazole2mg30's (Aripiprazole2mg30s)

Aripiprazole Tablets 2 mg oral dosage form label from Exelan Pharmaceuticals, Inc. The label includes the NDC number 76282-044-30, instructions for the pharmacist to dispense the Medication Guide separately, storage conditions, manufacturer and labeler information, and a barcode. The package contains 30 tablets.*

FDA Label Image

Aripiprazole30mg30's (Aripiprazole30mg30s)

Aripiprazole Tablets 30 mg label from Exelan Pharmaceuticals, Inc. The label features the product name and strength prominently, instructions for pharmacists to dispense medication guides, storage instructions, manufacturer details, and a barcode with NDC 76282-049-30. The package contains 30 tablets and includes a note on usual dosage and storage conditions.*

FDA Label Image

Aripiprazole5mg30's (Aripiprazole5mg30s)

Aripiprazole Tablets 5 mg oral tablets packaging label from Exelan Pharmaceuticals, Inc. The label states the strength as 5 mg, includes storage instructions, pharmacist dispensing guidance, manufacturer details for Exelan Pharmaceuticals, Inc. (Lawrenceville, GA), and notes 30 tablets per package labeled for Rx only use.*

FDA Label Image

Figure-6 (Figure 6)

A line graph depicting the proportion of subjects experiencing relapse over time (days from randomization) comparing Aripiprazole and placebo groups. The x-axis shows days from randomization up to 182 days, and the y-axis shows the proportion with relapse from 0.0 to 1.0. The graph includes a risk table indicating the number of subjects at risk at various time points for each group.*

FDA Label Image

Figure1 (Figure1)

A chart titled 'Effect of Other Drugs on Aripiprazole' showing the fold change and 90% confidence interval of Aripiprazole exposure (AUC and Cmax) when co-administered with various drugs, including ketoconazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam. The x-axis represents change relative to reference (without interacting drug) ranging from 0.0 to 3.0.*

FDA Label Image

Figure2 (Figure2)

A pharmacokinetic chart titled 'Effect of Other Drugs on Aripiprazole' showing fold changes with 90% confidence intervals for Dehydro-Aripiprazole. The graph compares the relative changes in AUC and Cmax for several interacting drugs, including CYP3A4 inhibitor ketoconazole, CYP2D6 inhibitor quinidine, CYP3A4 inducer carbamazepine, gastric acid blocker famotidine, and others such as valproate, lithium, and lorazepam. The x-axis represents fold change relative to reference without interacting drug.*

FDA Label Image

Figure3 (Figure3)

A forest plot chart titled 'Effect of Aripiprazole on Other Drugs' showing fold change and 90% confidence intervals for various drugs metabolized by enzymes CYP2D6, CYP2C9, 2C19, UGT1A4, and others. The horizontal axis represents the change relative to a reference without interacting drug, ranging from 0.5 to 3.0. Drugs listed include dextromethorphan, warfarin (S- and R-), omeprazole, lamotrigine, valproate, lithium, lorazepam, venlafaxine and its metabolite O-desmethylvenlafaxine. The chart displays pharmacokinetic parameters such as DMRP, AUC, Cmax, and INR with fold change values mostly near 1.0, indicating little to moderate interaction with Aripiprazole.*

FDA Label Image

Figure4 (Figure4)

A pharmacokinetic chart titled 'Aripiprazole Fold Change and 90% CI' showing fold changes in AUC and Cmax for different special populations relative to reference. It compares CYP2D6 poor versus extensive metabolizers, gender, age groups, hepatic impairment levels, and severe renal impairment, depicting fold change values with 90% confidence intervals on a horizontal axis ranging from 0.0 to 3.0.*

FDA Label Image

Figure5 (Figure5)

A forest plot chart showing the fold change and 90% confidence intervals of Dehydro-Aripiprazole pharmacokinetics (AUC and Cmax) relative to reference groups. Variables compared include CYP2D6 metabolizer status, gender, age groups, hepatic impairment severity, and severe renal impairment, with fold change values displayed along the x-axis.*

FDA Label Image

Structure (Structure)

Chemical structure of aripiprazole, the active ingredient shown in the image, depicted as a molecular diagram with labeled bonds and atoms including nitrogen, oxygen, chlorine, and carbon.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.